PWMG
ALNY icon

Private Wealth Management Group’s Alnylam Pharmaceuticals ALNY Stock Holding History

Private Wealth Management Group’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.7K Sell
62
-1
-2% -$302 ﹤0.01% 405
2026
Q1 		$20.8K Buy
63
+1
+2% +$340 0.01% 327
2025
Q4 		$24.7K Hold
62
– – 0.01% 280
2025
Q3 		$28.3K Hold
62
– – 0.01% 263
2025
Q2 		$20.2K Buy
62
+11
+22% +$3.04K 0.01% 301
2025
Q1 		$13.8K Buy
51
+43
+538% +$11.1K 0.01% 383
2024
Q4 		$1.88K Hold
8
– – ﹤0.01% 1107
2024
Q3 		$2.2K Hold
8
– – ﹤0.01% 1024
2024
Q2 		$1.94K Sell
8
-26
-76% -$4.11K ﹤0.01% 1057
2024
Q1 		$5.08K Buy
34
+8
+31% +$1.33K ﹤0.01% 620
2023
Q4 		$4.98K Buy
+26
New +$4.43K ﹤0.01% 628

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Private Wealth Management Group's ALNY Position: Q2 2026 in Review

Private Wealth Management Group reduced its Alnylam Pharmaceuticals (ALNY) stake by 1.6% in Q2 2026, selling an estimated $302 and leaving 62 shares worth $18.7K. The position accounts for ﹤0.01% of the portfolio, ranked #405.

Private Wealth Management Group first reported a position in ALNY in Q4 2023 and has held it in 11 quarters since. The position peaked at $28.3K in Q3 2025. 790 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Private Wealth Management Group held 62 shares of Alnylam Pharmaceuticals worth $18.7K as of Q2 2026.
  • Private Wealth Management Group sold 1 Alnylam Pharmaceuticals share in Q2 2026, an estimated $302.
  • Alnylam Pharmaceuticals made up ﹤0.01% of Private Wealth Management Group's portfolio in Q2 2026, its #405 holding.
  • Private Wealth Management Group first reported a position in Alnylam Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
  • Private Wealth Management Group's Alnylam Pharmaceuticals position peaked at $28.3K in Q3 2025.
  • 790 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Private Wealth Management Group's 13F filing for Q2 2026, filed 27 Jul 2026.